Revenue | {{ Info.Revenue | formatUSD }} |
Headquarters | {{ Info.Headquarters }} |
Registration status | Registration Changed to AVIDITY PARTNERS MANAGEMENT LP |
Exempt Reporting Adviser
2B(3)- PF>150mn
act solely as an adviser to private funds but you are no longer eligible to check box 2.B.(2) because you have assets under management, as defined in rule 203(m)-1, in the United States of $150 million or more |
|
Private Fund GAV* | 0 |
SMA’s | No |
Private Funds | 0 |
Contact Info | 214 xxxxxxx |
Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
---|---|---|---|---|---|
Stck Ticker156944100 | Stock NameCG ONCOLOGY INC | $ Position$38,998,492 | % Position8.00% | $ Change62.00% | # Change53.00% |
Stck Ticker101137107 | Stock NameBOSTON SCIENTIFIC CORP | $ Position$34,564,538 | % Position7.00% | $ Change2.00% | # Change-4.00% |
Stck Ticker632307104 | Stock NameNATERA INC | $ Position$33,669,742 | % Position7.00% | $ Change100.00% | # Change67.00% |
Stck Ticker252828108 | Stock NameDIANTHUS THERAPEUTICS INC | $ Position$32,470,264 | % Position6.00% | $ Change4.00% | # Change1.00% |
Stck Ticker235851102 | Stock NameDANAHER CORPORATION | $ Position$17,719,338 | % Position4.00% | $ Change94.00% | # Change102.00% |
Stck Ticker252131107 | Stock NameDEXCOM INC | $ Position$18,374,545 | % Position4.00% | $ Change49.00% | # Change17.00% |
Stck Ticker30063P105 | Stock NameEXACT SCIENCES CORP | $ Position$18,864,700 | % Position4.00% | $ Change23.00% | # Change1.00% |
Stck Ticker88033G407 | Stock NameTENET HEALTHCARE CORP | $ Position$18,656,000 | % Position4.00% | $ Change93.00% | # Change47.00% |
Stck Ticker759916109 | Stock NameREPLIGEN CORP | $ Position$13,246,470 | % Position3.00% | $ Change | # Change |
Stck Ticker372303206 | Stock NameGENMAB A/S | $ Position$13,429,000 | % Position3.00% | $ Change | # Change |